CJC-1295 with Ipamorelin outperforms sermorelin in any delivery form: This combination stimulates growth hormone through dual receptor activation, produces longer-lasting pulses than sermorelins short half-life allows, and does not increase cortisol or appetite
CJC-1295 WITH DAC (Drug Affinity Complex): Standard protocol: Total weekly: 2mg Split into: 1mg twice weekly (Monday/Thursday) OR: Single 2mg injection weekly Duration: 12-16 weeks Conservative protocol: Total weekly: 1mg Single injection weekly Good for first-timers Still effective, lower cost Aggressive protocol: Total weekly: 3-4mg Split into 1.5-2mg twice weekly Used by advanced users Diminishing returns above 2mg for most Why DAC version: Long half-life (6-8 days) Sustained GH elevation Weekly or twice-weekly injections (convenient) Most popular version CJC-1295 WITHOUT DAC (Mod GRF 1-29): Standard protocol: Dose: 100mcg per injection Frequency: 2-3x daily Timing: With Ipamorelin doses Total weekly: 1.4-2.1mg (200-300mcg daily) Typical schedule: Morning: 100mcg CJC + 200mcg Ipamorelin Post-workout: 100mcg CJC + 200mcg Ipamorelin Before bed: 100mcg CJC + 200mcg Ipamorelin Why without DAC: Mimics natural GH pulses Doesn't desensitize pituitary More "natural" approach More frequent injections (downside) Which to choose: Choose WITH DAC if: Want convenience Don't want daily injections Okay with steady GH elevation Most people choose this Choose WITHOUT DAC if: Want natural pulsing GH Already injecting daily (stacking) Prefer physiological approach Don't mind multiple daily injections FREE TOOLS FAQ What does "stacking" peptides mean
The math is straightforward: $249/mo equals $2,988 per year if maintained continuously, $399/mo equals $4,788 per year
Common Analytical Testing Methods Research-grade Ipamorelin peptide products are commonly evaluated using: High-performance liquid chromatography (HPLC) Mass spectrometry Molecular weight analysis Assay testing Purity verification These analytical methods help confirm peptide sequence consistency and laboratory research quality
Published studies may describe observable responses within specific experimental models
At our clinic, patients with any oncological history are screened carefully before any growth hormone-adjacent therapy is considered, and Sermorelin is routinely excluded from those protocols
